Skip to main content

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.

Funding Organization:
The US Department of Health and Human Services National Institutes of Health
Funding Category:
HIV/AIDS
Other Health-Related
Support Types:
Discretionary Grants
Locations:
International
Fund ID:
RFA-DA-25-024
Application Due Date:
Subjects:
AIDS
Clinical Research
Data Analysis
HIV
Audiences:
At Risk Persons
People with substance use disorder
Persons with HIV/AIDS
Researchers
Application Contact
Kathleen
Borgmann Ph.D.
Scientific/Research Contact- NIDA
3015946561
Kahtleen.Borgmann@nih.gov
Technical Contact
Pam
Fleming
Financial/Grants Management Contact- NIDA
3014801159
pfleming@mail.nih.gov
Was this page helpful?